 SI-BONE Inc NASDAQ: SIBN has announced the publication of 2-year results from the SALLY study of the iFuse-3D Implant System. Clinical results at 24 months showed marked and sustained improvements in the sacroiliac SI joint pain, patient function, and quality of life. 